Piperine is a chemopreventive agent that inhibits P-glycoprotein and/or CYP3A4; therefore, it increases the bioavailability of drugs that are the substrate for PGP/CYP3A as well as increasing the sensitivity of cancer cells at the site of tumors [24]. Here, CYP3A4 is linked to cancer.